Basel Medical Group's halt on Bitcoin acquisitions reflects the growing caution among institutions due to unclear U.S. regulations affecting digital assets.
Basel Medical Group Ltd has announced the suspension of its Bitcoin acquisition strategy, citing ongoing regulatory uncertainty in the U.S. regarding digital assets. This decision underscores the challenges faced by institutions in the current regulatory environment, which may impede further adoption of cryptocurrencies.